Highly purified lipopolysaccharides from Burkholderia cepacia complex clinical isolates induce inflammatory cytokine responses via TLR4-mediated MAPK signalling pathways and activation of NFκB

Cellular Microbiology

Volumn 9, Issue 2, 2007, Pages 532-543

  Bamford, Sarah ^a   Ryley, Henry ^a   Jackson, Simon K ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CYTOKINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

ANIMAL CELL; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATION; INHIBITION KINETICS; MONOCYTE; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INDUCTION; SEPSIS; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE;

BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CELLS, CULTURED; CYTOKINES; HUMANS; LIPOPOLYSACCHARIDES; MAP KINASE KINASE 1; NF-KAPPA B; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA MULTIVORANS;

EID: 33846227916     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2006.00808.x     Document Type: Article

References (49)

1. Beutler, B. (2000) TLR4: Central component of the sole mammalian LPS sensor. Curr Opin Immunol 12: 20-26.
2. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein-dye binding. Anal Biochem 72: 248.
3. Brandenburg, K., and Wiese, A. (2004) Endotoxins: Relationships between structure, function, and activity. Curr Top Med Chem 4: 1127-1146.
4. Brennan, P., and O'Neill, L.A. (1995) Effects of oxidants and antioxidants on nuclear factor kappa B activation in three different cell lines: Evidence against a universal hypothesis involving oxygen radicals. Biochim Biophys Acta 1260: 167-175.
5. DaSilva Correia, J., Soldau, K., Christen, U., Tobias, P.S., and Ulevitch, R.J. (2001) Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: Transfer from CD14 to TLR4 and MD-2. J Biol Chem 276: 21129-21135.
6. De Soyza, A., McDowell, A., Archer, L., Dark, J.H., Elborn, S.J., Mahenthrialingam, E., et.al. (2001) Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 358: 1780-1781.
7. De Soyza, A., Ellis, C.D., Khan, C.M., Corris, P.A., and Demarco de Hormaeche, R. (2004) Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. Am J Respir Crit Care Med 170: 70-77.
8. Ernst, R.K., Yi, E.C., Guo, L., Lim, K.B., Burns, J.L., Hackett, M., and Miller, S.I. (1999) Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286: 1561-1565.
9. Erridge, C., Pridmore, A., Eley, A., Stewart, J., and Poxton, I.R. (2004) Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via toll-like receptor 2. J Med Microbiol 53: 735-740.
10. Esen, N., and Kielian, T. (2005) Recognition of Staphylococcus aureus -derived peptidoglycan (PGN) but not intact bacteria is mediated by CD14 in microglia. J Neuroimmunol 170: 93-104.
11. Govan, J.R., Hughes, J.E., and Vandamme, P. (1996) Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol 45: 395-407.
12. Guha, M., and Mackman, N. (2001) LPS induction of gene expression in human monocytes. Cell Signal 13: 85-94.
13. Hajjar, A.M., Ernst, R.K., Tsai, J.H., Wilson, C.B., and Miller, S.I. (2002) Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 3: 354-359.
14. Hughes, J.E., Stewart, J., Barclay, G.R., and Govan, J.R.W. (1997) Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect Immun 65: 4281-4287.
15. Isles, A., Maclusky, I., Corey, M., Gold, R., Probe, R.C., Fleming, P., and Levison, H. (1984) Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 104: 206-210.
16. Jiang, Z., Georgel, P., Du, X., Shamel, L., Sovath, S., Mudd, S., et.al. (2005) CD14 is required for MyD88-independent LPS signalling. Nat Immunol 6: 565-570.
17. Karin M., and Ben-Neriah, Y. (2000) Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu Rev Immunol 18: 621-663.
18. Kawai, T., Takeuchi, O., Fujita, T., Inoue, J., Muhlradt, P.F., Sato, S., et.al. (2001) Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of interferon-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167: 5887-5894.
19. Kirschning, C.J., Wesche, H., Merrill, A.T., and Rothe, M. (1998) Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 188: 2091-2097.
20. Kurt-Jones, E.A., Popova, L., Kwinn, L., Haynes, L.M., Jones, L.P., Tripp, R.A., et.al. (2000) Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1: 398-401.
21. Ledson, M.J., Gallagher, M.J., Corkill, J.E., Hart, C.A., and Walshaw, M.J. (1998) Cross-infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax 53: 432-436.
22. LiPuma, J.J. (1998) Burkholderia cepacia. Management issues and new insights. Clin Chest Med 19: 473-486.
23. LiPuma, J.J., Spilker, T., Gill, L.H., Campbell, P.W., Liu, L., and Mahenthiralingam, E. (2001) Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 164: 92-96.
24. Mahenthiralingam, E., Campbell, M.E., Henry, D.A., and Speert, D.P. (1996) Epidemiology of Burkholderia cepacia Infection in patients with cystic fibrosis: Analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol 34: 2914-2920.
25. Mahenthiralingam, E., Bischof, J., Byrne, S.K., Radomski, C., Davies, J.E., Av-Gay, Y., and Vandamme, P. (2000) DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 38: 3165-3173.
26. Mahenthiralingam, E., Urban, T.A., and Goldberg, J.B. (2005) The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 3: 144-156.
27. Muhdi, K., Edenborough, F.P., Gumery, L., O'Hickey, S., Smith, E.G., Smith, D.L., and Stableforth, D.E. (1996) Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic. Thorax 51: 374-377.
28. Nick, J.A., Avdi, J.N., Young, S.K., McDonald, P.P., Billstrom, M.A., Henson, P.M., et.al. (1999) An intracellular signaling pathway linking lipopolysaccharide stimulation to cellular responses human neutrophil. Chest 116: 54S-55S.
29. Palsson-McDermott, E.M., and O'Neill, L.A.J. (2004) Signal transduction by the lipopolysaccharide receptor, Toll-like receptor 4. Immunology 113: 153-162.
30. Rao, K.M. (2001) MAPkinase activation in macrophages. J Leukoc Biol 69: 3-10.
31. Reddi, K., Phagoo, S.B., Anderson, K.D., and Warburton, D. (2003) Burkholderia cepacia -induced IL-8 gene expression in an alveolar epithelial cell line: Signaling through CD14 and mitogen-activated protein kinase. Pediatr Res 54: 297-305.
32. Rehli, M. (2002) of mice and men: Species variations of Toll-like receptor expression. Trends Immunol 23: 375-378.
33. Rhee, S.H., Jones, B.W., Toshchakov, V., Vogel, S.N., and Fenton, M.J. (2003) Toll-like receptors 2 and 4 activate STAT 1 serine phosphorylation by distinct mechanisms in macrophages. J Biol Chem 278: 22506-22512.
34. Ryley, H.C. (2004) Burkholderia cepacia complex infection in cystic fibrosis patients: Mechanisms of pathogenesis. Rev Med Microbiol 15: 93-101.
35. Ryley, H.C., and Doull, J.M. (2003) Burkholderia cepacia complex infection in patients with cystic fibrosis: Laboratory investigations, epidemiology and clinical management. Rev Med Microbiol 14: 15-24.
36. Ryley, H.C., Millar-Jones, L., Paull, A., and Weeks, J. (1995) Characterisation of Burkholderia cepacia from cystic fibrosis patients living in Wales by PCR ribotyping. J Med Microbiol 43: 436-441.
37. Schroeder, T.H., Lee, M.M., Yacono, P.W., Cannon, C.L., Gerceker, A.A., Golan, D.E., and Pier, G.B. (2002) CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation. Proc Natl Acad Sci USA 99: 6907-6912.
38. Shaw, D., Poxton, I.R., and Govan, J.R. (1995) Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol Med Microbiol 11: 99-106.
39. Shimomura, H., Matsuura, M., Saito, S., Hirai, Y., Isshiki, Y., and Kawahara, K. (2001) Lipopolysaccharide of Burkholderia cepacia and its unique ability to stimulate murine macrophages with a relative lack of interleukin-1β-inducing ability. Infect Immun 69: 3663-3669.
40. Shimomura, H., Matsuura, M., Saito, S., Hirai, Y., Isshiki, Y., and Kawahara, K. (2003) Unusual interaction of a lipopolysaccharide isolated from Burkholderia cepacia with polymyxin B. Infect Immun 71: 5225-5230.
41. Silipo, A., Molinaro, A., Cescutti, P., Bedini, E., Rizzo, R., Parrilli, M., and Lanzetta, R. (2005) Complete structural characterization of the lipid A fraction of a clinical strain of B.cepacia genomovar I lipopolysaccharide. Glycobiology 15: 561-570.
42. Trent, M.S. (2004) Biosynthesis, transport, and modification of lipid A. Biochem Cell Biol 82: 71-86.
43. Urban, T.A., Griffith, A., Torok, A.M., Smolkin, M.E., Burns, J.L., and Goldberg, J.B. (2004) Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation. Infect Immun 72: 5126-5134.
44. Vinion-Dubiel, A.D., and Goldberg, J.B. (2003) Lipopolysaccharide of the Burkholderia cepacia complex. J Endotoxin Res 9: 201-213.
45. Werts, C., Tapping, R.I., Mathison, J.C., Chuang, T.H., Kravchenko, V., Saint Girons, I., et.al. (2001) Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2: 346-352.
46. Ziegler-Heitbrock, H.W. (1994) Distinct patterns of differentiation induced in the monocytic cell line Mono Mac 6. J Leukoc Biol 55: 73-80.
47. Zughaier, S., Ryley, H.C., and Jackson, S.K. (1999a) LPS from B.cepacia is more active than LPS from P.aeruginosa and St.maltophilia in stimulating TNFα from human monocytes. Infect Immun 67: 1505-1507.
48. Zughaier, S.M., Ryley, H.C., and Jackson, S.K. (1999b) A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates monocyte respiratory burst activity by scavenging superoxide anion. Infect Immun 67: 908-913.
49. Zughaier, S.M., Zimmer, S.M., Datta, A., Carlson, R.W., and Stephens, D.S. (2005) Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun 73: 2940-2950.